Shiga toxin-producing Escherichia coli O157 is more likely to lead to hospitalization and death than Non-O157 serogroups - Except O104

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Preueß, Karina ^a,b   Hoḧle, Michael ^a   Stark, Klaus ^a   Werber, Dirk ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; ESCHERICHIA COLI O157; FEMALE; GERMANY; HEMOLYTIC-UREMIC SYNDROME; HOSPITALIZATION; HUMANS; INFANT; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SPECIES SPECIFICITY;

EID: 84893698133     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078180     Document Type: Article

References (51)

1. Donnenberg MS, Whittam TS (2001) Pathogenesis and evolution of virulence in enteropathogenic and enterohemorrhagic Escherichia coli. J Clin Invest 107: 539-548. (Pubitemid 32205174)
2. Ogura Y, Ooka T, Iguchi A, Toh H, Asadulghani M, et al. (2009) Comparative genomics reveal the mechanism of the parallel evolution of O157 and non-O157 enterohemorrhagic Escherichia coli. Proc Natl Acad Sci U S A 106: 17939-17944.
3. Souza MR, Klassen G, Toni FD, Rigo LU, Henkes C, et al. (2010) Biochemical properties, enterohaemolysin production and plasmid carriage of Shiga toxin-producing Escherichia coli strains. J Clin Microbiol 105: 318-321.
4. Mead PS, Griffin PM (1998) Escherichia coli O157:H7. Lancet 352: 1207-1212. (Pubitemid 28458545)
5. Werber D, Behnke SC, Fruth A, Merle R, Menzler S, et al. (2007) Shiga toxin-producing Escherichia coli infection in Germany: different risk factors for different age groups. Am J Epidemiol 165: 425-434.
6. Banatvala N, Griffin PM, Greene KD, Barrett TJ, Bibb WF, et al. (2001) The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings. J Infect Dis 183: 1063-1070. (Pubitemid 32230954)
7. Verweyen HM, Karch H, Allerberger F, Zimmerhackl LB (1999) Enterohemorrhagic Escherichia coli (EHEC) in pediatric hemolytic-uremic syndrome: a prospective study in Germany and Austria. Infection 27: 341-347.
8. March SB, Ratnam S (1986) Sorbitol-MacConkey medium for detection of Escherichia coli O157:H7 associated with hemorrhagic colitis. J Clin Microbiol 23: 869-872. (Pubitemid 16120609)
9. Karmali MA (1989) Infection by verocytotoxin-producing Escherichia coli. Clin Microbiol Rev 2: 15-38. (Pubitemid 19031864)
10. Bettelheim KA (2007) The non-O157 shiga-toxigenic (verocytotoxigenic) Escherichia coli; under-rated pathogens. Crit Rev Microbiol 33: 67-87.
11. Brooks JT, Sowers EG, Wells JG, Greene KD, Griffin PM, et al. (2005) Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002. J Infect Dis 192: 1422-1429. (Pubitemid 41401157)
12. Werber D, Beutin L, Pichner R, Stark K, Fruth A (2008) Shiga toxin-producing Escherichia coli serogroups in food and patients, Germany. Emerg Infect Dis 14: 1803-1806.
13. Gould LH, Mody RK, Ong KL, Clogher P, Cronquist AB, et al. (2013) Increased recognition of non-O157 Shiga toxin-producing Escherichia coli infections in the United States during 2000-2010: epidemiologic features and comparison with E. coli O157 infections. Foodborne Pathog Dis 10: 453-460.
14. Fey PD, Wickert RS, Rupp ME, Safranek TJ, Hinrichs SH (2000) Prevalence of non-O157:H7 shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska. Emerg Infect Dis 6: 530-533.
15. Lockary VM, Hudson RF, Ball CL (2007) Shiga toxin-producing Escherichia coli, Idaho. Emerg Infect Dis 13: 1262-1264. (Pubitemid 47359184)
16. Jelacic JK, Damrow T, Chen GS, Jelacic S, Bielaszewska M, et al. (2003) Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles. J Infect Dis 188: 719-729. (Pubitemid 37115185)
17. Buvens G, De Gheldre Y, Dediste A, de Moreau AI, Mascart G, et al. (2012) Incidence and virulence determinants of verocytotoxin-producing Escherichia coli infections in the Brussels-Capital Region, Belgium, in 2008-2010. J Clin Microbiol 50: 1336-1345.
18. Wylie JL, Van Caeseele P, Gilmour MW, Sitter D, Guttek C, et al. (2013) Evaluation of a new chromogenic agar medium for detection of Shiga toxin-producing Escherichia coli (STEC) and relative prevalences of O157 and non-O157 STEC in Manitoba, Canada. J Clin Microbiol 51: 466-471.
19. Gould LH, Bopp C, Strockbine N, Atkinson R, Baselski V, et al. (2009) Recommendations for diagnosis of shiga toxin-producing Escherichia coli infections by clinical laboratories. MMWR Recomm Rep 58: 1-14.
20. Hadler JL, Clogher P, Hurd S, Phan Q, Mandour M, et al. (2011) Ten-year trends and risk factors for non-O157 Shiga toxin-producing Escherichia coli found through Shiga toxin testing, Connecticut, 2000-2009. Clin Infect Dis 53: 269-276.
21. Hedican EB, Medus C, Besser JM, Juni BA, Koziol B, et al. (2009) Characteristics of O157 versus non-O157 Shiga toxin-producing Escherichia coli infections in Minnesota, 2000-2006. Clin Infect Dis 49: 358-364.
22. Rangel JM, Sparling PH, Crowe C, Griffin PM, Swerdlow DL (2005) Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982-2002. Emerg Infect Dis 11: 603-609. (Pubitemid 40462912)
23. Hermos CR, Janineh M, Han LL, McAdam AJ (2011) Shiga toxin-producing Escherichia coli in children: diagnosis and clinical manifestations of O157:H7 and non-O157:H7 infection. J Clin Microbiol 49: 955-959.
24. Johnson KE, Thorpe CM, Sears CL (2006) The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clin Infect Dis 43: 1587-1595. (Pubitemid 44901903)
25. McPherson M, Lalor K, Combs B, Raupach J, Stafford R, et al. (2009) Serogroup-specific risk factors for Shiga toxin-producing Escherichia coli infection in Australia. Clin Infect Dis 49: 249-256.
26. Clogher P, Hurd S, Hoefer D, Hadler JL, Pasutti L, et al. (2012) Assessment of physician knowledge and practices concerning Shiga toxin-producing Escherichia coli infection and enteric illness, 2009, Foodborne Diseases Active Surveillance Network (FoodNet). Clin Infect Dis 54 Suppl 5: S446-452.
27. Stigi KA, Macdonald JK, Tellez-Marfin AA, Lofy KH (2012) Laboratory practices and incidence of non-O157 shiga toxin-producing Escherichia coli infections. Emerg Infect Dis 18: 477-479.
28. Buvens G, Pierard D (2012) Virulence profiling and disease association of verocytotoxin-producing Escherichia coli O157 and non-O157 isolates in Belgium. Foodborne Pathog Dis 9: 530-535.
29. Blanco JE, Blanco M, Alonso MP, Mora A, Dahbi G, et al. (2004) Serotypes, virulence genes, and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from human patients: prevalence in Lugo, Spain, from 1992 through 1999. J Clin Microbiol 42: 311-319. (Pubitemid 38082738)
30. Klein EJ, Stapp JR, Clausen CR, Boster DR, Wells JG, et al. (2002) Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study. J Pediatr 141: 172-177.
31. Lathrop S, Edge K, Bareta J (2009) Shiga toxin-producing Escherichia coli, New Mexico, USA, 2004-2007. Emerg Infect Dis 15: 1289-1291.
32. Manning SD, Madera RT, Schneider W, Dietrich SE, Khalife W, et al. (2007) Surveillance for Shiga toxin-producing Escherichia coli, Michigan, 2001-2005. Emerg Infect Dis 13: 318-321. (Pubitemid 46193183)
33. Gould LH, Demma L, Jones TF, Hurd S, Vugia DJ, et al. (2009) Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006. Clin Infect Dis 49: 1480-1485.
34. Frank C, Werber D, Cramer JP, Askar M, Faber M, et al. (2011) Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med 365: 1771-1780.
35. Cleveland WS (1979) Robust locally weighted regression and smoothing scatterplots. Journal of the American Statistical Association 74: 829-836.
36. Zou G (2004) A Modified Poisson Regression Approach to Prospective Studies with Binary Data. Am J Epidemiol 159: 702-706.
37. Bundesrepublik-Deutschland (2000) Gesetz zur Verhütung und Bekämpfung von Infektionskrankheiten beim Menschen (Infektionsschutzgesetz - IfSG). Bundesgesetzblatt, Teil I, Nr. 33. pp. 1045-1077.
38. Werber D, Fruth A, Heissenhuber A, Wildner M, Prager R, et al. (2004) Shiga toxin-producing Escherichia coli O157 more frequently cause bloody diarrhea than do non-O157 strains. J Infect Dis 189: 1335-1336; author reply 1336-1337.
39. Nielsen S, Frank C, Fruth A, Spode A, Prager R, et al. (2011) Desperately seeking diarrhoea: outbreak of haemolytic uraemic syndrome caused by emerging sorbitol-fermenting shiga toxin-producing Escherichia coli O157:H-, Germany, 2009. Zoonoses Public Health 58: 567-572.
40. Brzuszkiewicz E, Thurmer A, Schuldes J, Leimbach A, Liesegang H, et al. (2011) Genome sequence analyses of two isolates from the recent Escherichia coli outbreak in Germany reveal the emergence of a new pathotype: Entero-Aggregative-Haemorrhagic Escherichia coli (EAHEC). Arch Microbiol 193: 883-891.
41. Bielaszewska M, Mellmann A, Zhang W, Kock R, Fruth A, et al. (2011) Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect Dis 11: 671-676.
42. King LA, Nogareda F, Weill FX, Mariani-Kurkdjian P, Loukiadis E, et al. (2012) Outbreak of Shiga toxin-producing Escherichia coli O104:H4 associated with organic fenugreek sprouts, France, June 2011. Clin Infect Dis 54: 1588-1594.
43. Loos S, Ahlenstiel T, Kranz B, Staude H, Pape L, et al. (2012) An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children. Clin Infect Dis 55: 753-759.
44. Werber D, King LA, Muller L, Follin P, Buchholz U, et al. (2013) Associations of Age and Sex With the Clinical Outcome and Incubation Period of Shiga toxin-producing Escherichia coli O104:H4 Infections, 2011. Am J Epidemiol.
45. Soborg B, Lassen S, Muller L, Jensen T, Ethelberg S, et al. (2013) A verocytotoxin-producing E. coli outbreak with a surprisingly high risk of haemolytic uraemic syndrome, Denmark, September-October 2012. Euro Surveill 18.
46. Boerlin P, McEwen SA, Boerlin-Petzold F, Wilson JB, Johnson RP, et al. (1999) Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol 37: 497-503. (Pubitemid 29091254)
47. Ostroff SM, Tarr PI, Neill MA, Lewis JH, Hargrett-Bean N, et al. (1989) Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J Infect Dis 160: 994-998. (Pubitemid 20002767)
48. Friedrich AW, Bielaszewska M, Zhang WL, Pulz M, Kuczius T, et al. (2002) Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J Infect Dis 185: 74-84. (Pubitemid 34043019)
49. Holtz LR, Neill MA, Tarr PI (2009) Acute bloody diarrhea: a medical emergency for patients of all ages. Gastroenterology 136: 1887-1898.
50. Hickey CA, Beattie TJ, Cowieson J, Miyashita Y, Strife CF, et al. (2011) Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome. Arch Pediatr Adolesc Med 165: 884-889.
51. Werber D, Mason BW, Evans MR, Salmon RL (2008) Preventing household transmission of Shiga toxin-producing Escherichia coli O157 infection: promptly separating siblings might be the key. Clin Infect Dis 46: 1189-1196. (Pubitemid 351589901)